APA   Click to copy
Lock, R., Ingraham, R., Maertens, O., Miller, A. L., Weledji, N., Legius, E., … Cichowski, K. (2016). Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers. The Journal of Clinical Investigation, 126, 2181–2190. https://doi.org/10.1172/JCI85183

Chicago/Turabian   Click to copy
Lock, Rebecca, Rachel Ingraham, Ophélia Maertens, Abigail L. Miller, Nelly Weledji, Eric Legius, Bruce M. Konicek, Sau-Chi B. Yan, Jeremy R. Graff, and Karen Cichowski. “Cotargeting MNK and MEK Kinases Induces the Regression of NF1-Mutant Cancers.” The Journal of Clinical Investigation 126 (June 2016): 2181–2190.

MLA   Click to copy
Lock, Rebecca, et al. “Cotargeting MNK and MEK Kinases Induces the Regression of NF1-Mutant Cancers.” The Journal of Clinical Investigation, vol. 126, The American Society for Clinical Investigation, June 2016, pp. 2181–90, doi:10.1172/JCI85183.

@article{lock2016a,
  title = {Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers},
  year = {2016},
  month = jun,
  journal = {The Journal of Clinical Investigation},
  pages = {2181-2190},
  publisher = {The American Society for Clinical Investigation},
  volume = {126},
  doi = {10.1172/JCI85183},
  author = {Lock, Rebecca and Ingraham, Rachel and Maertens, Ophélia and Miller, Abigail L. and Weledji, Nelly and Legius, Eric and Konicek, Bruce M. and Yan, Sau-Chi B. and Graff, Jeremy R. and Cichowski, Karen},
  month_numeric = {6}
}